What is Blood Glucose Test Strips Market?
Blood glucose test strips are small disposable strips used to measure the concentration of glucose (sugar) in a person's blood. They are a crucial component of blood glucose monitoring systems, commonly used by individuals with diabetes to monitor their blood sugar levels. Further, the increasing number of patients with diabetic conditions driving the demand for blood glucose test strips. In addition, growing healthcare infrastructure in developing economies is expected to drive the demand for blood glucose test strips over the forecasted period.
Highlights from Blood Glucose Test Strips Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Abbott Laboratories (United States), AgaMatrix, Inc., (Germany), PHC Holdings Corporation (Japan), LifeScan, Inc. (Johnson & Johnson), Roche Holding AG (Switzerland), Sanofi (France), Ypsomed Holding (Switzerland), Trividia Health, Inc. (United States), B. Braun Holding GmbH & Co. KG (Germany) and Prodigy Diabetes Care (United States) |
Ensuring high-quality and accurate test strips is crucial in the blood glucose monitoring market. Manufacturers may focus on maintaining strict quality control processes and obtaining certifications or approvals from regulatory bodies to demonstrate the reliability and accuracy of their products. Emphasizing the precision and consistency of their test strips can help build trust and loyalty among healthcare professionals and individuals with diabetes. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Blood Glucose Test Strips market throughout the forecasted period.
Abbott Laboratories (United States), AgaMatrix, Inc., (Germany), PHC Holdings Corporation (Japan), LifeScan, Inc. (Johnson & Johnson), Roche Holding AG (Switzerland), Sanofi (France), Ypsomed Holding (Switzerland), Trividia Health, Inc. (United States), B. Braun Holding GmbH & Co. KG (Germany) and Prodigy Diabetes Care (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Decision Diagnostics Corp (United States), DarioHealth (Israel) and Nipro (Japan). Blood Glucose Test Strips Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Type 1 Diabetes, Type 2 Diabetes and Others |
Technology | Glucose Oxidase,Glucose Dehydrogenase |
Distribution Channel | Retail Pharmacy,Hospital Pharmacy,Online Retailer |
End-User | Individuals,Hospitals & Clinics,Diagnostic Centre,Others |
On the basis of geography, the market of Blood Glucose Test Strips has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Ongoing Research and Development Activities for Novel Diabetes Products
Market Growth Drivers:
Increasing Prevalence of Diabetes and Growing Awareness about the Diabetic Care Devices
Challenges:
Lack of Awareness in the Emerging Countries
Restraints:
Stringent Government Regulations Regarding Medical Devices
Opportunities:
Growing Geriatric Population and Growing Healthcare Infrastructure in the Developing Economies
Key Target Audience
Blood Glucose Test Strips and Related Devices Manufacturers, Suppliers and Distributors of Blood Glucose Test Strips, Hospitals, Diagnostic Centers, Homecare Service Providers, and Medical Colleges, Teaching Hospitals and Academic Medical Centers, Government Bodies/Municipal Corporations, Business Research and Consulting Service Providers and Others
Market Leaders & Development Strategies
In April 2019, The Food and Drug Administration issued a warning against the use of test strips not authorized for sale in the United States and from a previous owner as they can cause infection.
In May 2019, Decision Diagnostics Corp announced to launch highly precise diabetes testing system, the panacea genultimate TBG diabetic test strip.
“According to The Food and Drug Administration (FDA) regulates blood glucose test strips as medical devices. In the home testing market, FDA advises consumers to buy only unopened vials of glucose test strips designed for their meter and never to purchase “pre-owned” test strips, which often are sold at a discount. FDA advises against their use because consumers would not be able to determine several factors, such as whether the strips were stored properly, expired, or contaminated by the previous owner.”